Login / Signup

Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis.

Krzysztof MarciniecArtur BeberokPaweł PęcakStanisław BoryczkaDorota Wrześniok
Published in: Pharmacological reports : PR (2020)
Here, we have demonstrated for the first time that ciprofloxacin and moxifloxacin may interact with COVID-19 Main Protease (Mpro).
Keyphrases
  • sars cov
  • pseudomonas aeruginosa
  • respiratory syndrome coronavirus
  • coronavirus disease
  • molecular docking
  • cystic fibrosis
  • data analysis